LB Pharmaceuticals Inc (LBRX)

Currency in USD
19.97
-1.41(-6.59%)
Closed·
20.36+0.39(+1.95%)
·
LBRX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
19.3021.80
52 wk Range
13.3623.15
Key Statistics
Prev. Close
21.38
Open
21.35
Day's Range
19.3-21.8
52 wk Range
13.36-23.15
Volume
258.59K
Average Volume (3m)
263.61K
1-Year Change
-
Book Value / Share
13.82
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LBRX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
44.50
Upside
+122.83%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

LB Pharmaceuticals Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell

LB Pharmaceuticals Inc Company Profile

LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead product is LB-102, a small molecule oral product, which is in Phase 3 clinical trial for the treatment of acute schizophrenia; completed Phase 1 clinical trial for the treatment of bipolar I depression; and in pr clinical stage for the treatment of LAI formulation. The company was incorporated in 2015 and is headquartered in New York, New York.

Compare LBRX to Peers and Sector

Metrics to compare
LBRX
Peers
Sector
Relationship
P/E Ratio
−26.9x−3.7x−0.6x
PEG Ratio
-−0.010.00
Price/Book
1.6x1.1x2.6x
Price / LTM Sales
-5.9x3.4x
Upside (Analyst Target)
72.8%209.1%39.6%
Fair Value Upside
Unlock15.0%5.2%Unlock

Analyst Ratings

4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 44.50
(+122.83% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Roth/MKM
Buy31.00+55.23%-New CoverageJan 09, 2026
Stifel
Buy35.00+75.26%27.00MaintainDec 11, 2025

Earnings

Latest Release
Nov 06, 2025
EPS / Forecast
-0.61 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

LBRX Income Statement

People Also Watch

17.00
MPLT
-8.01%
22.55
JCAP
-1.05%
40.77
MAZE
+2.41%
117.10
ABVX
+0.26%
9.620
ERAS
+0.63%

FAQ

What Is the LB Pharmaceuticals (LBRX) Stock Price Today?

The LB Pharmaceuticals stock price today is 19.97

What Stock Exchange Does LB Pharmaceuticals Trade On?

LB Pharmaceuticals is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for LB Pharmaceuticals?

The stock symbol for LB Pharmaceuticals is "LBRX."

What Is the LB Pharmaceuticals Market Cap?

As of today, LB Pharmaceuticals market cap is 505.22M.

What Is LB Pharmaceuticals's Earnings Per Share (TTM)?

The LB Pharmaceuticals EPS (TTM) is -0.74.

When Is the Next LB Pharmaceuticals Earnings Date?

LB Pharmaceuticals will release its next earnings report on Feb 25, 2026.

From a Technical Analysis Perspective, Is LBRX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has LB Pharmaceuticals Stock Split?

LB Pharmaceuticals has split 0 times.

How Many Employees Does LB Pharmaceuticals Have?

LB Pharmaceuticals has 16 employees.

What is the current trading status of LB Pharmaceuticals (LBRX)?

As of Jan 20, 2026, LB Pharmaceuticals (LBRX) is trading at a price of 19.97, with a previous close of 21.38. The stock has fluctuated within a day range of 19.30 to 21.80, while its 52-week range spans from 13.36 to 23.15.

What Is LB Pharmaceuticals (LBRX) Price Target According to Analysts?

The average 12-month price target for LB Pharmaceuticals is USD44.5, with a high estimate of USD78 and a low estimate of USD31. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +122.83% Upside potential.

What Is the LBRX After Hours Price?

LBRX's last after hours stock price is 20.36, the stock has decreased by 0.39, or 1.95%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.